Streamline HME Projects With Early Partner Engagement

By Ania VanDyke and Jared Baird, AbbVie Operations Science and Technology, AbbVie Contract Manufacturing

Hot‑melt extrusion offers an effective path for improving the solubility and bioavailability of poorly soluble compounds by transforming them into stable amorphous solid dispersions. Success depends on deep understanding of polymer miscibility, thermal behavior, and the complex interactions between an active ingredient and its excipients. Partnering early with a knowledgeable development organization helps ensure formulations are both scientifically sound and commercially scalable, preventing challenges such as recrystallization, instability, or processes that fail during scale‑up. Experienced teams bring expertise in materials science, formulation strategy, process modeling, and analytical method development, enabling the rapid identification of robust design spaces and efficient transfers across manufacturing scales. Access to a broad network of extrusion equipment, small‑scale modeling tools, and advanced analytical capabilities further strengthens project outcomes. This early, integrated approach accelerates development, reduces risk, supports patient‑centric design, and lays the foundation for reliable long‑term manufacturing success.